Ipilimumab-induced Ocular and Orbital Inflammation—A Case Series and Review of the Literature

Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma

(2014) B. Liao et al.   NEURO-ONCOLOGY

Ipilimumab in the treatment of metastatic melanoma: management of adverse events

(2014) Giuseppina Della Vittoria Scarpati et al.   OncoTargets and Therapy

Myosite orbitaire associée à un traitement par ipilimumab

(2013) M. Lecouflet et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma

(2013) Bobeck S. Modjtahedi et al.   Cutaneous and Ocular Toxicology

Melanoma-Associated Retinopathy Treated with Ipilimumab Therapy

(2013) A. Audemard et al.   DERMATOLOGY

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

(2013) Caroline J. Voskens et al.   PLoS One

Drug-Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in Two Patients After Treatment With Ipilimumab, an Antagonist of CTLA-4

(2013) Barbara L. Goldstein et al.   Arthritis & Rheumatology

Anti–Cytotoxic T-Cell Lymphocyte Antigen-4–Induced Regression of Spinal Cord Metastases in Association With Renal Failure, Atypical Pneumonia, Vision Loss, and Hearing Loss

(2012) Caroline Voskens et al.   JOURNAL OF CLINICAL ONCOLOGY

Ipilimumab for advanced melanoma: A pharmacologic perspective

(2012) Van Anh Trinh et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Drug-Induced Graves Disease From CTLA-4 Receptor Suppression

(2011) Gary Borodic et al.   OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy

(2010) Le Min et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma

(2008) Jeffrey S. Weber et al.   JOURNAL OF CLINICAL ONCOLOGY